105.76
+1.88
+(1.81%)
At close: 8:01:02 AM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 6 | 3 | 14 | 13 |
Avg. Estimate | 7.28B | 7.9B | 29.85B | 31.42B |
Low Estimate | 5.33B | 7.62B | 26.28B | 29.33B |
High Estimate | 7.82B | 8.17B | 30.81B | 32.81B |
Year Ago Sales | 7.21B | 7.67B | 29.06B | 29.85B |
Sales Growth (year/est) | 1.00% | 3.01% | 2.73% | 5.24% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
D2MN.F | -- | -- | -- | -- |
S&P 500 | 9.26% | 11.36% | 13.91% | 13.52% |
Upgrades & Downgrades
Maintains | Scotiabank: Sector Perform to Sector Perform | 12/12/2024 |
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 11/22/2024 |
Downgrade | Keybanc: Overweight to Sector Weight | 10/22/2024 |
Upgrade | Mizuho: Neutral to Outperform | 10/15/2024 |
Maintains | Barclays: Overweight to Overweight | 10/1/2024 |
Maintains | Keybanc: Overweight to Overweight | 9/30/2024 |